This article provides a year in review by featuring top non-COVID infectious diseases articles of 2021. Article Selection by: Bassam Ghanem, Pharm.D., MS, BCPS Post Construction by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Last Updated: 28 December 2021 For the field of infectious diseases 2021 has been a year for the record books. The … [Read more...]
The Intersection of Race & Antimicrobial Stewardship
In this article two infectious diseases pharmacists discuss the intersection of race and antimicrobial stewardship. Authored by: Jacinda C. Abdul-Mutakabbir PharmD, MPH, AAHIVP and Brenda Simiyu PharmD, BCPS, BCIDP Article Posted: 4 December 2021 The Coronavirus (COVID-19) pandemic has showcased many health inequities that exist amongst racially and … [Read more...]
Antimicrobial Stewardship In Nigeria: A Pharmacist’s Perspective
In this article a community pharmacist passionate about safe and rational use of antimicrobial agents discusses antimicrobial stewardship in Nigeria. Interview with: Precious Gospel, B.Pharm, MPSN, MIAPHL Community Pharmacist at Healthwel-bridge Pharmacy Interview by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Editor-In-Chief, … [Read more...]
Curve Your Enthusiasm: AUC-Guided Vancomycin Dosing and Monitoring
In this article perspectives on AUC-guided vancomycin dosing and monitoring are provided. Article Author: Sara Lee, Pharm.D. Article Mentor: Monica Mehta, Pharm.D., MPH, BCPS Article Posted 27 November 2021 Vancomycin is a glycopeptide antibiotic that has been used in clinical practice for over 50 years. Its early use was associated with … [Read more...]
Maximizing The Potential Of Rapid Diagnostics To Fight Antimicrobial Resistance
In this article two infectious diseases experts describe the importance of rapid diagnostics to fight against antimicrobial resistance in today's inter-connected world. Authored By: Christine Ginocchio, Ph.D., MT, (RET) & Tristan Timbrook, Pharm.D. Article Posted: 26 October, 2021 Antimicrobial Stewardship: Who’s Responsible? According to … [Read more...]






